A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis

Clinical trial NCT07387549 · RECRUITING

Trial details

NCT number: NCT07387549
Sponsor: Ipsen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis

Start date: 2026-05-14
Primary completion: 2031-04-30
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.